FR2642649A1 - - Google Patents

Download PDF

Info

Publication number
FR2642649A1
FR2642649A1 FR9001332A FR9001332A FR2642649A1 FR 2642649 A1 FR2642649 A1 FR 2642649A1 FR 9001332 A FR9001332 A FR 9001332A FR 9001332 A FR9001332 A FR 9001332A FR 2642649 A1 FR2642649 A1 FR 2642649A1
Authority
FR
France
Prior art keywords
composition according
lower alkyl
alkyl
thromboxane
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR9001332A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2642649A1 publication Critical patent/FR2642649A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9001332A 1989-02-06 1990-02-06 Pending FR2642649A1 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30673489A 1989-02-06 1989-02-06

Publications (1)

Publication Number Publication Date
FR2642649A1 true FR2642649A1 (da) 1990-08-10

Family

ID=23186608

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9001332A Pending FR2642649A1 (da) 1989-02-06 1990-02-06

Country Status (6)

Country Link
JP (1) JPH02270826A (da)
CA (1) CA2007896A1 (da)
DE (1) DE4003392A1 (da)
FR (1) FR2642649A1 (da)
GB (1) GB2227664A (da)
IT (1) IT1238082B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021448A (en) * 1990-02-22 1991-06-04 Ciba-Geigy Corporation Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor inhibitor and/or thromboxane receptor antagonist

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537981A (en) * 1981-11-09 1985-08-27 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene compounds
US4663336A (en) * 1985-07-01 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs useful in the treatment of thrombotic disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416896A (en) * 1982-05-17 1983-11-22 E. R. Squibb & Sons, Inc. 7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537981A (en) * 1981-11-09 1985-08-27 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene compounds
US4663336A (en) * 1985-07-01 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs useful in the treatment of thrombotic disease

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HYPERTENSION, vol. 12, no. 3, 1988, pages 287-294; R.J. ROMAN et al.: "Influence of eicosanoids on renal function of DOCA-salt hypertensive rats" *
PHARMACOLOGY, vol. 34, no. 6, 1987, pages 301-308, S. KARGER AG, Basel, CH; W.A. SCHUMACHER et al.: "Effect of the thromboxane A2-receptor antanogists, SQ 29,548 and SQ 28,668, on the pulmonary hypertensive response to endotoxemia in swine" *
THE AMERICAN JOURNAL OF MEDICAL SCIENCE, vol. 295, no. 4, 1988, pages 263-267; M. MISTRY et al.: "Prostanoids as mediators of prohypertensive and antihypertensive mechanisms" *
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 235, no. 2, 1985, pages 274-281, The American Society for Pharmalocogy and Experimental Therapeutics, US; H. DARUS et al.: "Beneficial effects of a new potent and specific thromboxane receptor antanogist (SQ-29,548) in Vitro and in Vivo" *

Also Published As

Publication number Publication date
IT9019256A0 (it) 1990-02-05
GB2227664A (en) 1990-08-08
CA2007896A1 (en) 1990-08-06
DE4003392A1 (de) 1990-08-09
GB9002194D0 (en) 1990-03-28
JPH02270826A (ja) 1990-11-05
IT1238082B (it) 1993-07-05
IT9019256A1 (it) 1990-08-07

Similar Documents

Publication Publication Date Title
US8440678B2 (en) Pharmaceutical composition
RU2005102110A (ru) Способ и лекарственное средство для лечения тяжелой сердечной недостаточности
JP2024083476A (ja) 糖尿病性末梢神経障害のための医薬
KR0149491B1 (ko) 뇌혈관 장해치료제로서의 7-치환 아미노-8-치환카르보닐-메틸아미노-1-옥사스피로(4,5)데칸
US4839384A (en) Method of inhibiting onset of or treating migraine headache using a thromboxane A2 receptor antagonist
KR930007252B1 (ko) 우울증 치료용 약학조성물
EP0351755B1 (en) Combination of a calcium channel blocker and thromboxane a2 receptor antagonist or synthetase inhibitor and method for treating ischemia employing such combination
FR2642649A1 (da)
CA1336168C (en) Method of preventing or treating toxemia in pregnancy using a thromboxane a_ receptor antagonist
US4558037A (en) Cardiovascular composition
US4931460A (en) Post-ischemic myocardial dysfunction using thromboxane A2 antagonists
AU602867B2 (en) Prostacyclines, their analogues or prostaglandines and thromboxane antagonists for the treatment of thrombotic and thrombo-embolic illnesses
US20060160887A1 (en) Medicinal composition
US4259346A (en) Bradycardiac pharmaceutical compositions and method of use
IE912821A1 (en) Method for preventing or treating cerebrovascular disease¹employing ceronapril
CA2076005A1 (en) Use of thromboxane-a2-receptor antagonists for the prevention of reduction of degenerative process in the penile tissue
US6201015B1 (en) Therapeutic method for thrombocytopathy treatment
KR0150182B1 (ko) 소염제로서의 7-치환 아미노-8-치환 카르보닐-메틸 아미노-1-옥사스피로(4,5)데칸
JPH02229112A (ja) 動脈硬化の予防または治療用組成物
RU2006117637A (ru) Комбинированное лечение ожирения с применением избирательных антагонистов cb1-рецептора и ингибиторов липаз
HUT52384A (en) Process for producing pharmaceutical compositions comprising dianhydrohexitol acyl derivatives
MXPA00010343A (en) Treatment of generalized anxiety disorder with paroxetine
BG104939A (bg) Лечение на общо чувство на безпокойство с пароксетин

Legal Events

Date Code Title Description
ER Errata listed in the french official journal (bopi)

Free format text: 32/90